Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

What drives operational performance in clinical R&D?

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Figure 1: Variation in performance among 14 companies.

Author information



Corresponding authors

Correspondence to Michael Ringel or Linda Martin.

Ethics declarations

Competing interests

The authors are employees of The Boston Consulting Group (BCG) and KMR Group, two organizations that consult with the world's leading biopharmaceutical companies on clinical R&D activities. The research for this specific article was funded by participating benchmark companies, BCG's health care practice and KMR Group.

PowerPoint slides

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Ringel, M., Martin, L., Hawkins, C. et al. What drives operational performance in clinical R&D?. Nat Rev Drug Discov 15, 155–156 (2016).

Download citation


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing